U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H20FN5O4.C4H7NO4.H2O
Molecular Weight 552.5096
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ZABOFLOXACIN D-ASPARTATE MONOHYDRATE

SMILES

O.N[C@H](CC(O)=O)C(O)=O.CO\N=C1/CN(CC12CNC2)C3=C(F)C=C4C(=O)C(=CN(C5CC5)C4=N3)C(O)=O

InChI

InChIKey=CKUBQLBJSAPAGK-WCRXHYIJSA-N
InChI=1S/C19H20FN5O4.C4H7NO4.H2O/c1-29-23-14-6-24(9-19(14)7-21-8-19)17-13(20)4-11-15(26)12(18(27)28)5-25(10-2-3-10)16(11)22-17;5-2(4(8)9)1-3(6)7;/h4-5,10,21H,2-3,6-9H2,1H3,(H,27,28);2H,1,5H2,(H,6,7)(H,8,9);1H2/b23-14+;;/t;2-;/m.1./s1

HIDE SMILES / InChI
Zabofloxacin (also known as DW-224a), a fluoroquinolone antibiotic agent, is a dual inhibitor of both DNA gyrase and topoisomerase IV of Streptococcus pneumonia. Zabofloxacin successfully has completed phase III clinical trial in patients with acute bacterial exacerbation of the chronic obstructive pulmonary disease. In addition, in May 2012, IASO terminated phase II trial of oral zabofloxacin capsules in patients with moderate-to-severe community-acquired pneumonia due to financial considerations.

Approval Year

PubMed

PubMed

TitleDatePubMed
New treatment options for lower respiratory tract infections.
2017-09
DNA gyrase and topoisomerase IV are dual targets of zabofloxacin in Streptococcus pneumoniae.
2010-07
Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains.
2008-09
Safety pharmacology of DW-224a, a novel fluoroquinolone antibiotic agent.
2004-11
Patents

Sample Use Guides

Zabofloxacin 367mg tablet P.O. once daily for 5days and then Placebo P.O. once daily for 2days
Route of Administration: Oral
Name Type Language
ZABOFLOXACIN D-ASPARTATE MONOHYDRATE
Common Name English
Zabofloxacin d-aspartate hydrate [WHO-DD]
Preferred Name English
D-ASPARTIC ACID, 1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-7-((8Z)-8-(METHOXYIMINO)-2,6-DIAZASPIRO(3.4)OCT-6-YL)-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLATE, HYDRATE (1:1:1)
Systematic Name English
Code System Code Type Description
FDA UNII
A09UU5N4TW
Created by admin on Tue Apr 01 21:25:43 GMT 2025 , Edited by admin on Tue Apr 01 21:25:43 GMT 2025
PRIMARY
SMS_ID
100000182643
Created by admin on Tue Apr 01 21:25:43 GMT 2025 , Edited by admin on Tue Apr 01 21:25:43 GMT 2025
PRIMARY
EVMPD
SUB196892
Created by admin on Tue Apr 01 21:25:43 GMT 2025 , Edited by admin on Tue Apr 01 21:25:43 GMT 2025
PRIMARY
PUBCHEM
131633976
Created by admin on Tue Apr 01 21:25:43 GMT 2025 , Edited by admin on Tue Apr 01 21:25:43 GMT 2025
PRIMARY
CAS
1808295-60-4
Created by admin on Tue Apr 01 21:25:43 GMT 2025 , Edited by admin on Tue Apr 01 21:25:43 GMT 2025
PRIMARY